Related Experiment Video
Updated: Apr 25, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Antagonists of IAP proteins: novel anti-tumor agents
Yichao Wan, Tingting Liu, Xuben Hou
1Department of Medicinal Chemistry, School of Pharmacy, Shandong University, 44 West Wenhua Road, Jinan, PR China. haofangcn@sdu.edu.cn.
Abstract:
Evasion of apoptosis is an important reason for tumor cells to resist the anticancer drugs in cancer therapy. As a critical regulator, the inhibitor of apoptosis proteins (IAPs) can block the apoptosis by inhibiting the activities of caspases. Scientists find that IAPs are over-expressed in many cancer cells, such as leukemia and B-cell lymphoma, which elucidate that high levels of IAPs are closely related to tumorigenesis and cancer development. Thus, targeting IAPs may be an attractive strategy for anti-tumor treatment. As an endogenous antagonist of IAPs, second mitochondria-derived activator of caspases (Smac) can suppress their activities through directly binding to IAPs. Based on structural biology study, Smac interacts with IAPs through the Ala-Val-Pro-Ile (AVPI) tetra-peptide of Smac. Therefore, many agents have been studied to suppress the IAPs which result in the activation of caspases and subsequently induce the apoptosis of tumor cells based on mimicking AVPI peptide strategy. In this review, the functions of IAPs in apoptosis and the recent advance of IAPs antagonists will be discussed.
Insights
Tumor cells resist cancer drugs by evading apoptosis. Inhibitor of apoptosis proteins (IAPs) promote cancer; targeting them with Smac-mimetic drugs can induce cancer cell death.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Evasion of apoptosis is a key mechanism of cancer drug resistance.
- Inhibitor of apoptosis proteins (IAPs) are over-expressed in cancers like leukemia and lymphoma, promoting tumor growth.
- IAPs inhibit caspases, crucial enzymes for programmed cell death.
Purpose of the Study:
- To review the role of IAPs in apoptosis.
- To discuss recent advances in developing IAP antagonists for cancer therapy.
Main Methods:
- Review of scientific literature on IAPs and their antagonists.
- Focus on structural biology studies of Smac-IAP interactions.
- Analysis of therapeutic strategies targeting IAPs.
Main Results:
- IAPs are critical regulators of apoptosis and are implicated in cancer development.
- Second mitochondria-derived activator of caspases (Smac) antagonizes IAPs.
- Smac utilizes an AVPI tetra-peptide motif to bind IAPs.
Conclusions:
- Targeting IAPs represents a promising anti-cancer strategy.
- Smac-mimetic agents designed to mimic the AVPI peptide can suppress IAPs.
- This suppression leads to caspase activation and apoptosis induction in tumor cells.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
08:51Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Caspases
The JAK-STAT Signaling Pathway
Cellular Injury V: Apoptosis and Autophagy
Apoptosis